Bausch Health Cos Inc (NYSE: BHC) stock suffered a major decline of -23.2% on 7/24/24. The shares closed at $5.81. Moreover, exceptionally high trading volume at 1635% of normal accompanied the decline. The stock has been weak relative to the market over the last nine months and has declined -23.0% during the last week.
Current PriceTarget Research Rating
BHC is expected to be an important Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment